DaVita, Inc. (NYSE:DVA)

CAPS Rating: 3 out of 5

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

Recs

0
Player Avatar MAURY56 (< 20) Submitted: 3/6/2011 1:26:34 AM : Outperform Start Price: $83.96 DVA Score: -2.05

Tops on Fortune list of most admired companies. Tops in some other list of copanies that train their employees well.

Featured Broker Partners


Advertisement